↓ Skip to main content

A Cost Analysis of Haemodialysis and Peritoneal Dialysis for the Management of End-Stage Renal Failure At an Academic Hospital in Pretoria, South Africa

Overview of attention for article published in PharmacoEconomics - Open, March 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#27 of 358)
  • High Attention Score compared to outputs of the same age (86th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
2 news outlets
twitter
4 X users
facebook
1 Facebook page

Citations

dimensions_citation
24 Dimensions

Readers on

mendeley
83 Mendeley
Title
A Cost Analysis of Haemodialysis and Peritoneal Dialysis for the Management of End-Stage Renal Failure At an Academic Hospital in Pretoria, South Africa
Published in
PharmacoEconomics - Open, March 2019
DOI 10.1007/s41669-019-0124-5
Pubmed ID
Authors

Letlhogonolo Makhele, Moliehi Matlala, Mncengeli Sibanda, Antony P. Martin, Brian Godman

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 83 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 83 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 21 25%
Student > Bachelor 10 12%
Other 5 6%
Researcher 5 6%
Student > Postgraduate 5 6%
Other 10 12%
Unknown 27 33%
Readers by discipline Count As %
Medicine and Dentistry 22 27%
Nursing and Health Professions 12 14%
Economics, Econometrics and Finance 8 10%
Social Sciences 5 6%
Pharmacology, Toxicology and Pharmaceutical Science 3 4%
Other 4 5%
Unknown 29 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 October 2023.
All research outputs
#2,051,518
of 24,567,524 outputs
Outputs from PharmacoEconomics - Open
#27
of 358 outputs
Outputs of similar age
#46,257
of 356,796 outputs
Outputs of similar age from PharmacoEconomics - Open
#1
of 15 outputs
Altmetric has tracked 24,567,524 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 358 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.5. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 356,796 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.